Atricure
AtriCure, Inc. is a medical device company focused on developing, manufacturing, and selling innovative devices for the surgical ablation of cardiac tissue, particularly for conditions such as atrial fibrillation. Headquartered near Cincinnati, Ohio, the company offers a diverse range of products including the Isolator Synergy and Isolator Synergy Access clamps for atrial fibrillation treatment, the EPi-Sense guided coagulation system, and the COBRA Fusion surgical ablation system, which integrates various energy control methods. AtriCure also provides multifunctional surgical pens, linear ablation devices, and cryoablation systems designed to treat cardiac arrhythmias and manage pain. In addition, the company manufactures instruments for left atrial appendage occlusion and cardiac surgery procedures. AtriCure distributes its products through a combination of direct sales personnel and independent distributors, primarily serving medical centers in the United States and internationally. Founded in 2000, AtriCure aims to enhance patient outcomes through less invasive surgical techniques.
SentreHEART, Inc., based in Redwood City, California, is a privately held medical device company that manufacturers the LARIAT Suture Delivery Device for remote delivery of a pre-tied suture loop. Innovation in catheter and suture delivery technology enables physicians to remotely deliver a 40mm pre-tied suture loop for immediate and complete soft tissue closure through access as small as 4.3mm and with no metal, clips or fabrics left behind. Regulatory clearance for soft tissue ligation and approximation has been received in the US, Europe, and Canada.
nContact, Inc. is a medical device company specializing in the development of innovative solutions for the treatment of cardiac arrhythmias, particularly atrial fibrillation. Founded in 2005 and based in Morrisville, North Carolina, the company focuses on minimally invasive ablation procedures. Its flagship product, the Numeris Coagulation System with VisiTrax, utilizes a unique combination of suction, perfusion, and radiofrequency energy to create visible, nonconductive lesions on the epicardium of a beating heart. This system has received regulatory approval for use in the United States and holds CE Mark approval in Europe. nContact also offers a range of other devices designed to ensure consistent contact with cardiac tissue, facilitating effective lesion creation. The company has initiated clinical studies to further explore its technology's application in treating atrial fibrillation through both open and closed chest procedures. In 2011, nContact, formerly known as nContact Surgical, became a subsidiary of AtriCure, Inc.
ESTECH is a privately held medical device manufacturing and distribution company located in San Ramon, California. The company was founded by Arthur and Raymond Bertolero in 1996 with an emphasis on least invasive products for cardiac surgery. ESTECH has worldwide distribution and has consistently attracted goal oriented professionals who represent the brightest minds in the medical device industry. The in-depth professional experience and tireless dedication of the ESTECH Team has allowed the company to achieve rapid and sustained success in this highly competitive environment. ESTECH is proud of each employee from every department and thanks them for their contribution and support.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.